Martin N. Bonde
Vorstandsvorsitzender bei Inthera Bioscience AG
Ursprung des Netzwerks ersten Grades von Martin N. Bonde
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
Visiopharm A/S
 Visiopharm A/S Packaged SoftwareTechnology Services Visiopharm A/S provides quantitative digital pathology solutions for biopharmaceutical companies, contract research organizations, academic medical centers, research institutes and hospitals. Its offers solutions such as BIOTOPIX, ONCOTOPIX, and STEREOTOPIX. The company was founded by Michael Grunkin and Johan Doré Hansen in 2001 and is headquartered in Horsholm, Denmark.
11
| Holding Company | Packaged Software | 11 |
Inthera Bioscience AG
 Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland.
6
| Holding Company | Biotechnology | 6 |
Bioinnovation Institute
 Bioinnovation Institute Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk A/S, Bioinnovation Institute is a non-profit foundation based in Copenhagen, Denmark. The Danish company offers a +1000 square meters of laboratory space to entrepreneurs and researchers in life science to bring interdisciplinary ideas to life and research to market. The program combines business acceleration, scientific development, and team development to help start-ups in the early phases. The CEO of the company is Jens Nielsen.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Biotopix ApS
1
| Private Company | 1 | |
Bii Holdings A/S
 Bii Holdings A/S Miscellaneous Commercial ServicesCommercial Services Bii Holdings A/S is a non-profit organization that operates an incubator for startup businesses in science and technology. The Danish company was founded by Doron Cohen.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Martin N. Bonde
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Technical University of Denmark | College/University | Chairman Graduate Degree Director/Board Member Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Aarhus | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Sales & Marketing | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Director/Board Member Chairman | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Antag Therapeutics ApS
 Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Chief Executive Officer | |
Falcon.io ApS
 Falcon.io ApS Packaged SoftwareTechnology Services Falcon.io ApS develops and operations social media management platform. The firm specializes in the design of systems features, such as track reach and content identification, content planning and social workflow, analytics, and reporting. Its solutions include social media management; social listening; content markleting; customer engagement; audience management; and agencies. The company was founded by Ulrik Bo Larsen and Morten Søderquist Li in 2010 and is headquartered in Copenhagen, Denmark. | Packaged Software | Chairman Chairman | |
Insurance Business Applications ApS
 Insurance Business Applications ApS Packaged SoftwareTechnology Services Insurance Business Applications ApS provides insurance software solutions. Its services include campaign management, multi-channel sales, policy administration system, claims management and micro tariffing. The company was founded by Anders Engdal and Søren Degn Jahns in 2010 and is headquartered in the Copenhagen, Denmark. | Packaged Software | Director/Board Member Chairman | |
| INTELEPEE | Internet Software/Services | Director/Board Member Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ABLYNX | Biotechnology | Chairman Director/Board Member | |
Bankinvest Biomedical Venture
 Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Dako Corp.
 Dako Corp. Medical/Nursing ServicesHealth Services Dako Corp. manufactures and markets cell based cancer diagnostics for both clinical diagnostics and research use. It is engaged in innovative detection systems, instrumentation antibodies for bioresearch, immunohistochemistry and flow cytometry. The company is located in Carpinteria, CA. | Medical/Nursing Services | Chief Executive Officer Corporate Officer/Principal | |
| VIROGATES A/S | Medical Specialties | Chairman Director/Board Member | |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Chairman Director/Board Member | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Chairman Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SEW-EURODRIVE AS
 SEW-EURODRIVE AS Electrical ProductsProducer Manufacturing SEW-EURODRIVE AS manufactures electric motors, generators, and transformers. The firm offers solutions such as turning and pivoting; handling and sorting; packaging; stationary conveying; storing; mixing and stirring; cooling; washing and drying; deconstruction and digging; and conveying and driving. The company was founded in 1977 and is headquartered in Moss, Norway. | Electrical Products | Director/Board Member | |
Plesner Advokatpartnerselskab
 Plesner Advokatpartnerselskab Miscellaneous Commercial ServicesCommercial Services Plesner Advokatpartnerselskab is a Danish legal services company. The private company is based in Copenhagen, Denmark. The company was founded in 1918 by Poul Jacobsen. Niklas Korsgaard Christensen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Consort Isefjord A/S | Director/Board Member | ||
| Consort KBH A/S | Director/Board Member | ||
| Inge & Skjold Burnes Fond | Director/Board Member | ||
| Invistra ApS | Director/Board Member | ||
Telsome ApS
 Telsome ApS Wireless TelecommunicationsCommunications Part of Network Capital Group Holding A/S, Telsome ApS provides Voice over Internet Protocol services. The company is based in Copenhagen, Denmark. Telsome was acquired by Network Capital Group Holding A/S on April 03, 2007. | Wireless Telecommunications | Director/Board Member |
Statistik
International
| Dänemark | 27 |
| Niederlande | 7 |
| Vereinigte Staaten | 5 |
| Schweden | 4 |
| Belgien | 4 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 5 |
| Technology Services | 4 |
| Finance | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 309 |
| Chairman | 92 |
| Corporate Officer/Principal | 82 |
| Independent Dir/Board Member | 58 |
| Chief Executive Officer | 52 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jens Harpøth Zilstorff | 37 |
| Bo Jesper Hansen | 34 |
| Georges Gemayel | 33 |
| Martijn Kleijwegt | 33 |
| Sten Scheibye | 31 |
| Anders Hedegaard | 30 |
| Rémi Droller | 29 |
| Catherine Moukheibir | 29 |
| Patrik Olof Dahlén | 28 |
| Sten Verland | 28 |
| Anker Gunvald Lundemose | 25 |
| Shomit Ghose | 23 |
| Emmanuelle Coutanceau | 21 |
| Thomas Weilby Knudsen | 18 |
| Klaus Schollmeier | 17 |
- Börse
- Insiders
- Martin N. Bonde
- Unternehmensverbindungen
